Comment on CMS-2026-1255-0001
GeneDxSupportBusiness
Summary: GeneDx, LLC, a laboratory company, supports the proposed action to improve interoperability and streamline prior authorization for laboratory tests. They argue that current rigid "date-of-service" requirements for specimen collection create unnecessary burdens on patients and providers, and they advocate for automated, AI-enabled workflows to improve access to care while maintaining program integrity.
See attached the formal response for GeneDx for the CMS Priori Authorization Request for Information (RFI).